XML 103 R22.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Supplemental Condensed Consolidating Financial Information | 9 Months Ended
--- | ---
Sep. 30, 2018
Condensed Financial Information [Abstract] |
Supplemental Condensed Consolidating Financial Information | Supplemental Condensed Consolidating Financial Information As discussed in Note 7, “Debt,” we have outstanding $700 million aggregate principal amount of 5.375% Notes due November 15, 2022, unless earlier redeemed. At September 30, 2018, the 5.375% Notes were fully and unconditionally guaranteed by certain of our wholly owned subsidiaries on a joint and several basis, with exceptions considered customary for such guarantees. For all periods presented, the following condensed consolidating financial statements present Molina Healthcare, Inc. (as “Parent Guarantor”), the subsidiary guarantors (as “Other Guarantors”), the subsidiary non-guarantors (as “Non-Guarantors”) and “Eliminations”, according to the guarantor structure as assessed as of and for the nine months ended September 30, 2018. In connection with the divestiture of MMS described in Note 11, “Segments,” MMS was released as an “Other Guarantor” effective September 30, 2018, and is reported in “Non-Guarantors” for all periods presented. In connection with the sale of all of the membership interests of our wholly owned subsidiary Pathways Health and Community Support LLC (Pathways) described in Note 1, “Organization and Basis of Presentation,” Pathways was released as an “Other Guarantor” effective October 19, 2018, leaving our wholly owned subsidiary Molina Pathways, LLC as the sole subsidiary guarantor as of that date. CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
| Three Months Ended September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 273 |  |  | $ | — |  |  | $ | 4,695 |  |  | $ | (271 | ) |  | $ | 4,697 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | (11 | ) |  | — |  |  | 3,801 |  |  | — |  |  | 3,790 |
Cost of service revenue | — |  |  | — |  |  | 111 |  |  | — |  |  | 111 |
General and administrative expenses | 243 |  |  | 1 |  |  | 338 |  |  | (271 | ) |  | 311 |
Premium tax expenses | — |  |  | — |  |  | 110 |  |  | — |  |  | 110 |
Health insurer fees | — |  |  | — |  |  | 87 |  |  | — |  |  | 87 |
Depreciation and amortization | 17 |  |  | — |  |  | 8 |  |  | — |  |  | 25 |
Restructuring and separation costs | 3 |  |  | — |  |  | 2 |  |  | — |  |  | 5 |
Total operating expenses | 252 |  |  | 1 |  |  | 4,457 |  |  | (271 | ) |  | 4,439 |
Gain on sale of subsidiary | 37 |  |  | — |  |  | — |  |  | — |  |  | 37 |
Operating income (loss) | 58 |  |  | (1 | ) |  | 238 |  |  | — |  |  | 295 |
Interest expense | 26 |  |  | — |  |  | — |  |  | — |  |  | 26 |
Other expenses, net | 10 |  |  | — |  |  | — |  |  | — |  |  | 10 |
Income (loss) before income taxes | 22 |  |  | (1 | ) |  | 238 |  |  | — |  |  | 259 |
Income tax (benefit) expense | (6 | ) |  | — |  |  | 68 |  |  | — |  |  | 62 |
Net income (loss) before equity in net earnings (losses) of subsidiaries | 28 |  |  | (1 | ) |  | 170 |  |  | — |  |  | 197 |
Equity in net earnings (losses) of subsidiaries | 169 |  |  | (2 | ) |  | — |  |  | (167 | ) |  | — |
Net income (loss) | $ | 197 |  |  | $ | (3 | ) |  | $ | 170 |  |  | $ | (167 | ) |  | $ | 197 |
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| Three Months Ended September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net income (loss) | $ | 197 |  |  | $ | (3 | ) |  | $ | 170 |  |  | $ | (167 | ) |  | $ | 197 |
Other comprehensive gain, net of tax | 1 |  |  | — |  |  | 1 |  |  | (1 | ) |  | 1 |
Comprehensive income (loss) | $ | 198 |  |  | $ | (3 | ) |  | $ | 171 |  |  | $ | (168 | ) |  | $ | 198 |
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
| Three Months Ended September 30, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 380 |  |  | $ | (1 | ) |  | $ | 5,031 |  |  | $ | (379 | ) |  | $ | 5,031 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | 3 |  |  | — |  |  | 4,217 |  |  | — |  |  | 4,220 |
Cost of service revenue | — |  |  | — |  |  | 123 |  |  | — |  |  | 123 |
General and administrative expenses | 244 |  |  | — |  |  | 518 |  |  | (379 | ) |  | 383 |
Premium tax expenses | — |  |  | — |  |  | 106 |  |  | — |  |  | 106 |
Depreciation and amortization | 23 |  |  | — |  |  | 10 |  |  | — |  |  | 33 |
Restructuring and separation costs | 77 |  |  | — |  |  | 41 |  |  | — |  |  | 118 |
Impairment losses | — |  |  | — |  |  | 129 |  |  | — |  |  | 129 |
Total operating expenses | 347 |  |  | — |  |  | 5,144 |  |  | (379 | ) |  | 5,112 |
Operating income (loss) | 33 |  |  | (1 | ) |  | (113 | ) |  | — |  |  | (81 | )
Interest expense | 32 |  |  | — |  |  | — |  |  | — |  |  | 32 |
Income (loss) before income taxes | 1 |  |  | (1 | ) |  | (113 | ) |  | — |  |  | (113 | )
Income tax expense (benefit) | 9 |  |  | (1 | ) |  | (24 | ) |  | — |  |  | (16 | )
Net loss before equity in net (losses) earnings of subsidiaries | (8 | ) |  | — |  |  | (89 | ) |  | — |  |  | (97 | )
Equity in net (losses) earnings of subsidiaries | (89 | ) |  | (86 | ) |  | 8 |  |  | 167 |  |  | — |
Net loss | $ | (97 | ) |  | $ | (86 | ) |  | $ | (81 | ) |  | $ | 167 |  |  | $ | (97 | )
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE LOSS
| Three Months Ended September 30, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net loss | $ | (97 | ) |  | $ | (86 | ) |  | $ | (81 | ) |  | $ | 167 |  |  | $ | (97 | )
Other comprehensive income, net of tax | — |  |  | — |  |  | — |  |  | — |  |  | — |
Comprehensive loss | $ | (97 | ) |  | $ | (86 | ) |  | $ | (81 | ) |  | $ | 167 |  |  | $ | (97 | )
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
| Nine Months Ended September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 867 |  |  | $ | 2 |  |  | $ | 14,220 |  |  | $ | (863 | ) |  | $ | 14,226 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | (4 | ) |  | — |  |  | 11,366 |  |  | — |  |  | 11,362 |
Cost of service revenue | — |  |  | — |  |  | 349 |  |  | — |  |  | 349 |
General and administrative expenses | 762 |  |  | 3 |  |  | 1,096 |  |  | (863 | ) |  | 998 |
Premium tax expenses | — |  |  | — |  |  | 320 |  |  | — |  |  | 320 |
Health insurer fees | — |  |  | — |  |  | 261 |  |  | — |  |  | 261 |
Depreciation and amortization | 53 |  |  | — |  |  | 23 |  |  | — |  |  | 76 |
Restructuring and separation costs | 28 |  |  | — |  |  | 10 |  |  | — |  |  | 38 |
Total operating expenses | 839 |  |  | 3 |  |  | 13,425 |  |  | (863 | ) |  | 13,404 |
Gain on sale of subsidiary | 37 |  |  | — |  |  | — |  |  | — |  |  | 37 |
Operating income (loss) | 65 |  |  | (1 | ) |  | 795 |  |  | — |  |  | 859 |
Interest expense | 90 |  |  | — |  |  | 1 |  |  | — |  |  | 91 |
Other expenses, net | 25 |  |  | — |  |  | — |  |  | — |  |  | 25 |
(Loss) income before income taxes | (50 | ) |  | (1 | ) |  | 794 |  |  | — |  |  | 743 |
Income tax expense | 4 |  |  | — |  |  | 233 |  |  | — |  |  | 237 |
Net (loss) income before equity in net earnings (losses) of subsidiaries | (54 | ) |  | (1 | ) |  | 561 |  |  | — |  |  | 506 |
Equity in net earnings (losses) of subsidiaries | 560 |  |  | (6 | ) |  | — |  |  | (554 | ) |  | — |
Net income (loss) | $ | 506 |  |  | $ | (7 | ) |  | $ | 561 |  |  | $ | (554 | ) |  | $ | 506 |
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
| Nine Months Ended September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net income (loss) | $ | 506 |  |  | $ | (7 | ) |  | $ | 561 |  |  | $ | (554 | ) |  | $ | 506 |
Other comprehensive loss, net of tax | (4 | ) |  | — |  |  | (4 | ) |  | 4 |  |  | (4 | )
Comprehensive income (loss) | $ | 502 |  |  | $ | (7 | ) |  | $ | 557 |  |  | $ | (550 | ) |  | $ | 502 |
CONDENSED CONSOLIDATING STATEMENTS OF OPERATIONS
| Nine Months Ended September 30, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Revenue: |  |  |  |  |  |  |  |  |
Total revenue | $ | 1,010 |  |  | $ | 1 |  |  | $ | 14,937 |  |  | $ | (1,014 | ) |  | $ | 14,934 |
Expenses: |  |  |  |  |  |  |  |  |
Medical care costs | 10 |  |  | — |  |  | 12,812 |  |  | — |  |  | 12,822 |
Cost of service revenue | — |  |  | — |  |  | 369 |  |  | — |  |  | 369 |
General and administrative expenses | 799 |  |  | 2 |  |  | 1,440 |  |  | (1,014 | ) |  | 1,227 |
Premium tax expenses | — |  |  | — |  |  | 331 |  |  | — |  |  | 331 |
Depreciation and amortization | 75 |  |  | — |  |  | 34 |  |  | — |  |  | 109 |
Restructuring and separation costs | 120 |  |  | — |  |  | 41 |  |  | — |  |  | 161 |
Impairment losses | — |  |  | — |  |  | 201 |  |  | — |  |  | 201 |
Total operating expenses | 1,004 |  |  | 2 |  |  | 15,228 |  |  | (1,014 | ) |  | 15,220 |
Operating income (loss) | 6 |  |  | (1 | ) |  | (291 | ) |  | — |  |  | (286 | )
Interest expense | 85 |  |  | — |  |  | — |  |  | — |  |  | 85 |
Other income, net | (75 | ) |  | — |  |  | — |  |  | — |  |  | (75 | )
Loss before income taxes | (4 | ) |  | (1 | ) |  | (291 | ) |  | — |  |  | (296 | )
Income tax expense (benefit) | 26 |  |  | (1 | ) |  | (71 | ) |  | — |  |  | (46 | )
Net loss before equity in net (losses) earnings of subsidiaries | (30 | ) |  | — |  |  | (220 | ) |  | — |  |  | (250 | )
Equity in net (losses) earnings of subsidiaries | (220 | ) |  | (152 | ) |  | 8 |  |  | 364 |  |  | — |
Net loss | $ | (250 | ) |  | $ | (152 | ) |  | $ | (212 | ) |  | $ | 364 |  |  | $ | (250 | )
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE LOSS
| Nine Months Ended September 30, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Net loss | $ | (250 | ) |  | $ | (152 | ) |  | $ | (212 | ) |  | $ | 364 |  |  | $ | (250 | )
Other comprehensive income, net of tax | 1 |  |  | — |  |  | 1 |  |  | (1 | ) |  | 1 |
Comprehensive loss | $ | (249 | ) |  | $ | (152 | ) |  | $ | (211 | ) |  | $ | 363 |  |  | $ | (249 | )
CONDENSED CONSOLIDATING BALANCE SHEETS
| September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
ASSETS
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 399 |  |  | $ | 2 |  |  | $ | 2,413 |  |  | $ | — |  |  | $ | 2,814 |
Investments | 106 |  |  | — |  |  | 1,706 |  |  | — |  |  | 1,812 |
Receivables | 2 |  |  | — |  |  | 1,344 |  |  | — |  |  | 1,346 |
Due from (to) affiliates | 63 |  |  | (4 | ) |  | (59 | ) |  | — |  |  | — |
Prepaid expenses and other current assets | 293 |  |  | — |  |  | 193 |  |  | — |  |  | 486 |
Derivative asset | 843 |  |  | — |  |  | — |  |  | — |  |  | 843 |
Total current assets | 1,706 |  |  | (2 | ) |  | 5,597 |  |  | — |  |  | 7,301 |
Property, equipment, and capitalized software, net | 187 |  |  | — |  |  | 77 |  |  | — |  |  | 264 |
Goodwill and intangible assets, net | 14 |  |  | — |  |  | 181 |  |  | — |  |  | 195 |
Restricted investments | — |  |  | — |  |  | 118 |  |  | — |  |  | 118 |
Investment in subsidiaries, net | 2,578 |  |  | 74 |  |  | — |  |  | (2,652 | ) |  | — |
Deferred income taxes | 48 |  |  | — |  |  | 95 |  |  | — |  |  | 143 |
Other assets | 40 |  |  | — |  |  | 6 |  |  | (16 | ) |  | 30 |
| $ | 4,573 |  |  | $ | 72 |  |  | $ | 6,074 |  |  | $ | (2,668 | ) |  | $ | 8,051 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities: |  |  |  |  |  |  |  |  |
Medical claims and benefits payable | $ | 4 |  |  | $ | — |  |  | $ | 2,038 |  |  | $ | — |  |  | $ | 2,042 |
Amounts due government agencies | — |  |  | — |  |  | 1,030 |  |  | — |  |  | 1,030 |
Accounts payable and accrued liabilities | 635 |  |  | — |  |  | 189 |  |  | — |  |  | 824 |
Deferred revenue | — |  |  | — |  |  | 178 |  |  | — |  |  | 178 |
Current portion of long-term debt | 296 |  |  | — |  |  | — |  |  | — |  |  | 296 |
Derivative liability | 843 |  |  | — |  |  | — |  |  | — |  |  | 843 |
Total current liabilities | 1,778 |  |  | — |  |  | 3,435 |  |  | — |  |  | 5,213 |
Long-term debt and lease financing obligations | 1,217 |  |  | — |  |  | 16 |  |  | (16 | ) |  | 1,217 |
Other long-term liabilities | 17 |  |  | — |  |  | 43 |  |  | — |  |  | 60 |
Total liabilities | 3,012 |  |  | — |  |  | 3,494 |  |  | (16 | ) |  | 6,490 |
Total stockholders’ equity | 1,561 |  |  | 72 |  |  | 2,580 |  |  | (2,652 | ) |  | 1,561 |
| $ | 4,573 |  |  | $ | 72 |  |  | $ | 6,074 |  |  | $ | (2,668 | ) |  | $ | 8,051 |
CONDENSED CONSOLIDATING BALANCE SHEETS
| December 31, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
ASSETS
Current assets: |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 504 |  |  | $ | — |  |  | $ | 2,682 |  |  | $ | — |  |  | $ | 3,186 |
Investments | 192 |  |  | — |  |  | 2,332 |  |  | — |  |  | 2,524 |
Restricted investments | 169 |  |  | — |  |  | — |  |  | — |  |  | 169 |
Receivables | 2 |  |  | — |  |  | 869 |  |  | — |  |  | 871 |
Due from (to) affiliates | 148 |  |  | (5 | ) |  | (143 | ) |  | — |  |  | — |
Prepaid expenses and other current assets | 103 |  |  | 16 |  |  | 136 |  |  | (16 | ) |  | 239 |
Derivative asset | 522 |  |  | — |  |  | — |  |  | — |  |  | 522 |
Total current assets | 1,640 |  |  | 11 |  |  | 5,876 |  |  | (16 | ) |  | 7,511 |
Property, equipment, and capitalized software, net | 223 |  |  | — |  |  | 119 |  |  | — |  |  | 342 |
Goodwill and intangible assets, net | 15 |  |  | — |  |  | 240 |  |  | — |  |  | 255 |
Restricted investments | — |  |  | — |  |  | 119 |  |  | — |  |  | 119 |
Investment in subsidiaries, net | 2,306 |  |  | 82 |  |  | — |  |  | (2,388 | ) |  | — |
Deferred income taxes | 17 |  |  | — |  |  | 101 |  |  | (15 | ) |  | 103 |
Other assets | 32 |  |  | — |  |  | 110 |  |  | (1 | ) |  | 141 |
| $ | 4,233 |  |  | $ | 93 |  |  | $ | 6,565 |  |  | $ | (2,420 | ) |  | $ | 8,471 |
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities: |  |  |  |  |  |  |  |  |
Medical claims and benefits payable | $ | 3 |  |  | $ | — |  |  | $ | 2,189 |  |  | $ | — |  |  | $ | 2,192 |
Amounts due government agencies | — |  |  | — |  |  | 1,542 |  |  | — |  |  | 1,542 |
Accounts payable and accrued liabilities | 178 |  |  | 14 |  |  | 174 |  |  | — |  |  | 366 |
Deferred revenue | — |  |  | — |  |  | 282 |  |  | — |  |  | 282 |
Current portion of long-term debt | 653 |  |  | — |  |  | 16 |  |  | (16 | ) |  | 653 |
Derivative liability | 522 |  |  | — |  |  | — |  |  | — |  |  | 522 |
Total current liabilities | 1,356 |  |  | 14 |  |  | 4,203 |  |  | (16 | ) |  | 5,557 |
Long-term debt and lease financing obligations | 1,516 |  |  | — |  |  | — |  |  | — |  |  | 1,516 |
Deferred income taxes | — |  |  | — |  |  | 15 |  |  | (15 | ) |  | — |
Other long-term liabilities | 24 |  |  | 1 |  |  | 37 |  |  | (1 | ) |  | 61 |
Total liabilities | 2,896 |  |  | 15 |  |  | 4,255 |  |  | (32 | ) |  | 7,134 |
Total stockholders’ equity | 1,337 |  |  | 78 |  |  | 2,310 |  |  | (2,388 | ) |  | 1,337 |
| $ | 4,233 |  |  | $ | 93 |  |  | $ | 6,565 |  |  | $ | (2,420 | ) |  | $ | 8,471 |
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
| Nine Months Ended September 30, 2018
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by (used in) operating activities | $ | 451 |  |  | $ | 1 |  |  | $ | (643 | ) |  | $ | — |  |  | $ | (191 | )
Investing activities: |  |  |  |  |  |  |  |  |
Purchases of investments | (136 | ) |  | — |  |  | (1,066 | ) |  | — |  |  | (1,202 | )
Proceeds from sales and maturities of investments | 383 |  |  | — |  |  | 1,687 |  |  | — |  |  | 2,070 |
Purchases of property, equipment and capitalized software | (16 | ) |  | — |  |  | (8 | ) |  | — |  |  | (24 | )
Capital contributions to subsidiaries | (122 | ) |  | — |  |  | 122 |  |  | — |  |  | — |
Dividends from subsidiaries | 268 |  |  | — |  |  | (268 | ) |  | — |  |  | — |
Change in amounts due to/from affiliates | 70 |  |  | 1 |  |  | (71 | ) |  | — |  |  | — |
Other, net | — |  |  | — |  |  | (23 | ) |  | — |  |  | (23 | )
Net cash provided by investing activities | 447 |  |  | 1 |  |  | 373 |  |  | — |  |  | 821 |
Financing activities: |  |  |  |  |  |  |  |  |
Repayment of credit facility | (300 | ) |  | — |  |  | — |  |  | — |  |  | (300 | )
Repayment of principal amount of 1.125% Notes | (236 | ) |  | — |  |  | — |  |  | — |  |  | (236 | )
Cash paid for partial settlement of 1.125% Conversion Option | (477 | ) |  | — |  |  | — |  |  | — |  |  | (477 | )
Cash received for partial termination of 1.125% Call Option | 477 |  |  | — |  |  | — |  |  | — |  |  | 477 |
Cash paid for partial termination of 1.125% Warrants | (419 | ) |  | — |  |  | — |  |  | — |  |  | (419 | )
Repayment of principal amount of 1.625% Notes | (64 | ) |  | — |  |  | — |  |  | — |  |  | (64 | )
Other, net | 7 |  |  | — |  |  | — |  |  | — |  |  | 7 |
Net cash used in financing activities | (1,012 | ) |  | — |  |  | — |  |  | — |  |  | (1,012 | )
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents | (114 | ) |  | 2 |  |  | (270 | ) |  | — |  |  | (382 | )
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 513 |  |  | — |  |  | 2,777 |  |  | — |  |  | 3,290 |
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 399 |  |  | $ | 2 |  |  | $ | 2,507 |  |  | $ | — |  |  | $ | 2,908 |
| Nine Months Ended September 30, 2017
| Parent Guarantor |  | Other Guarantors |  | Non-Guarantors |  | Eliminations |  | Consolidated
| (In millions)
Operating activities: |  |  |  |  |  |  |  |  |
Net cash provided by operating activities | $ | 215 |  |  | $ | — |  |  | $ | 742 |  |  | $ | — |  |  | $ | 957 |
Investing activities: |  |  |  |  |  |  |  |  |
Purchases of investments | (331 | ) |  | — |  |  | (1,563 | ) |  | — |  |  | (1,894 | )
Proceeds from sales and maturities of investments | 148 |  |  | — |  |  | 1,388 |  |  | — |  |  | 1,536 |
Purchases of property, equipment and capitalized software | (67 | ) |  | — |  |  | (18 | ) |  | — |  |  | (85 | )
Capital contributions to subsidiaries | (363 | ) |  | 2 |  |  | 361 |  |  | — |  |  | — |
Dividends from subsidiaries | 136 |  |  | — |  |  | (136 | ) |  | — |  |  | — |
Change in amounts due to/from affiliates | (100 | ) |  | — |  |  | 100 |  |  | — |  |  | — |
Other, net | — |  |  | — |  |  | (33 | ) |  | — |  |  | (33 | )
Net cash (used in) provided by investing activities | (577 | ) |  | 2 |  |  | 99 |  |  | — |  |  | (476 | )
Financing activities: |  |  |  |  |  |  |  |  |
Proceeds from senior notes offerings, net of issuance costs | 325 |  |  | — |  |  | — |  |  | — |  |  | 325 |
Proceeds from borrowings under credit facility | 300 |  |  | — |  |  | — |  |  | — |  |  | 300 |
Other, net | 7 |  |  | — |  |  | — |  |  | — |  |  | 7 |
Net cash provided by financing activities | 632 |  |  | — |  |  | — |  |  | — |  |  | 632 |
Net increase in cash, cash equivalents, and restricted cash and cash equivalents | 270 |  |  | 2 |  |  | 841 |  |  | — |  |  | 1,113 |
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period | 86 |  |  | — |  |  | 2,826 |  |  | — |  |  | 2,912 |
Cash, cash equivalents, and restricted cash and cash equivalents at end of period | $ | 356 |  |  | $ | 2 |  |  | $ | 3,667 |  |  | $ | — |  |  | $ | 4,025 |

X
- Definition Condensed Financial Information [Abstract] + References No definition available. + Details
Name: | moh_CondensedFinancialInformationAbstract
Namespace Prefix: | moh_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial statements. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph d -Subparagraph 4 -Subsection 10 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph c -Subparagraph 4 -Subsection 10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 12 -Paragraph a -Subsection 04 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph e -Subparagraph 4 -Subsection 10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 3 -Paragraph f -Subparagraph 4 -Subsection 10 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 + Details
Name: | srt_CondensedFinancialStatementsTextBlock
Namespace Prefix: | srt_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration